retatrutide phase 3 trial results just delivered the most powerful weight loss data ever recorded in a obesity trial. At 104 weeks, participants on the 12 mg dose lost an average of 85 pounds Retatrutide Phase 3: TRIUMPH Program

Personalized Treatment Plan: At Reza Health, we understand that weight loss is a personal journey

Some people find that the carbonation in sparkling water causes bloating when combined with the slower digestion of a GLP-1

According to the brand's published materials, NativePath recommends a minimum 90-day consistent use window to assess individual response

A February 2026 study in the Journal of Clinical Endocrinology & Metabolism found an 11% higher fragility fracture risk in older adults with Type 2 diabetes using GLP-1 medications versus those using other diabetes medications - though this was a retrospective study documenting association, not proven causation

References: 1.A